These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 24819299)
1. The role of Src family kinases in growth and migration of glioma stem cells. Han X; Zhang W; Yang X; Wheeler CG; Langford CP; Wu L; Filippova N; Friedman GK; Ding Q; Fathallah-Shaykh HM; Gillespie GY; Nabors LB Int J Oncol; 2014 Jul; 45(1):302-10. PubMed ID: 24819299 [TBL] [Abstract][Full Text] [Related]
2. Src family kinases differentially influence glioma growth and motility. Lewis-Tuffin LJ; Feathers R; Hari P; Durand N; Li Z; Rodriguez FJ; Bakken K; Carlson B; Schroeder M; Sarkaria JN; Anastasiadis PZ Mol Oncol; 2015 Nov; 9(9):1783-98. PubMed ID: 26105207 [TBL] [Abstract][Full Text] [Related]
3. The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion. Je DW; O YM; Ji YG; Cho Y; Lee DH Pancreas; 2014 Jul; 43(5):768-76. PubMed ID: 24763074 [TBL] [Abstract][Full Text] [Related]
4. Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients. Lu KV; Zhu S; Cvrljevic A; Huang TT; Sarkaria S; Ahkavan D; Dang J; Dinca EB; Plaisier SB; Oderberg I; Lee Y; Chen Z; Caldwell JS; Xie Y; Loo JA; Seligson D; Chakravari A; Lee FY; Weinmann R; Cloughesy TF; Nelson SF; Bergers G; Graeber T; Furnari FB; James CD; Cavenee WK; Johns TG; Mischel PS Cancer Res; 2009 Sep; 69(17):6889-98. PubMed ID: 19690143 [TBL] [Abstract][Full Text] [Related]
5. Lyn kinase mediates cell motility and tumor growth in EGFRvIII-expressing head and neck cancer. Wheeler SE; Morariu EM; Bednash JS; Otte CG; Seethala RR; Chiosea SI; Grandis JR Clin Cancer Res; 2012 May; 18(10):2850-60. PubMed ID: 22490227 [TBL] [Abstract][Full Text] [Related]
6. Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells. Eguchi R; Kubo S; Takeda H; Ohta T; Tabata C; Ogawa H; Nakano T; Fujimori Y Carcinogenesis; 2012 May; 33(5):969-75. PubMed ID: 22354875 [TBL] [Abstract][Full Text] [Related]
7. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells. Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970 [TBL] [Abstract][Full Text] [Related]
9. NT5DC2 promotes tumorigenicity of glioma stem-like cells by upregulating fyn. Guo S; Ran H; Xiao D; Huang H; Mi L; Wang X; Chen L; Li D; Zhang S; Han Q; Zhou T; Li A; Man J Cancer Lett; 2019 Jul; 454():98-107. PubMed ID: 30978441 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of Src family kinases with dasatinib blocks migration and invasion of human melanoma cells. Buettner R; Mesa T; Vultur A; Lee F; Jove R Mol Cancer Res; 2008 Nov; 6(11):1766-74. PubMed ID: 19010823 [TBL] [Abstract][Full Text] [Related]
11. Sublethal doxorubicin promotes migration and invasion of breast cancer cells: role of Src Family non-receptor tyrosine kinases. Mohammed S; Shamseddine AA; Newcomb B; Chavez RS; Panzner TD; Lee AH; Canals D; Okeoma CM; Clarke CJ; Hannun YA Breast Cancer Res; 2021 Jul; 23(1):76. PubMed ID: 34315513 [TBL] [Abstract][Full Text] [Related]
12. Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells. van Oosterwijk JG; van Ruler MA; Briaire-de Bruijn IH; Herpers B; Gelderblom H; van de Water B; Bovée JV Br J Cancer; 2013 Sep; 109(5):1214-22. PubMed ID: 23922104 [TBL] [Abstract][Full Text] [Related]
13. Src kinases catalytic activity regulates proliferation, migration and invasiveness of MDA-MB-231 breast cancer cells. Sánchez-Bailón MP; Calcabrini A; Gómez-Domínguez D; Morte B; Martín-Forero E; Gómez-López G; Molinari A; Wagner KU; Martín-Pérez J Cell Signal; 2012 Jun; 24(6):1276-86. PubMed ID: 22570868 [TBL] [Abstract][Full Text] [Related]
14. The stem cell marker CD133 (prominin-1) is phosphorylated on cytoplasmic tyrosine-828 and tyrosine-852 by Src and Fyn tyrosine kinases. Boivin D; Labbé D; Fontaine N; Lamy S; Beaulieu E; Gingras D; Béliveau R Biochemistry; 2009 May; 48(18):3998-4007. PubMed ID: 19296573 [TBL] [Abstract][Full Text] [Related]
15. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Soeda A; Park M; Lee D; Mintz A; Androutsellis-Theotokis A; McKay RD; Engh J; Iwama T; Kunisada T; Kassam AB; Pollack IF; Park DM Oncogene; 2009 Nov; 28(45):3949-59. PubMed ID: 19718046 [TBL] [Abstract][Full Text] [Related]
16. CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer. Chen YS; Wu MJ; Huang CY; Lin SC; Chuang TH; Yu CC; Lo JF PLoS One; 2011; 6(11):e28053. PubMed ID: 22140506 [TBL] [Abstract][Full Text] [Related]
17. The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling. Ping YF; Yao XH; Jiang JY; Zhao LT; Yu SC; Jiang T; Lin MC; Chen JH; Wang B; Zhang R; Cui YH; Qian C; Wang Jm; Bian XW J Pathol; 2011 Jul; 224(3):344-54. PubMed ID: 21618540 [TBL] [Abstract][Full Text] [Related]
18. Differential effects on cell motility, embryonic stem cell self-renewal and senescence by diverse Src kinase family inhibitors. Tamm C; Galitó SP; Annerén C Exp Cell Res; 2012 Feb; 318(4):336-49. PubMed ID: 22197704 [TBL] [Abstract][Full Text] [Related]
19. The Src and c-Kit kinase inhibitor dasatinib enhances p53-mediated targeting of human acute myeloid leukemia stem cells by chemotherapeutic agents. Dos Santos C; McDonald T; Ho YW; Liu H; Lin A; Forman SJ; Kuo YH; Bhatia R Blood; 2013 Sep; 122(11):1900-13. PubMed ID: 23896410 [TBL] [Abstract][Full Text] [Related]
20. Dual inhibition of Src and PLK1 regulate stemness and induce apoptosis through Notch1-SOX2 signaling in EGFRvIII positive glioma stem cells (GSCs). Li X; Tao Z; Wang H; Deng Z; Zhou Y; Du Z Exp Cell Res; 2020 Nov; 396(1):112261. PubMed ID: 32896567 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]